Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
5.25
+0.18 (3.55%)
Oct 13, 2025, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $196.04 million as of October 14, 2025. Its market cap has increased by 172.44% in one year.
Market Cap
196.04M
Enterprise Value
169.77M
1-Year Change
172.44%
Ranking
Category
Stock Price
$5.25
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $196.04M, an increase of 38.35%. That is a compound annual growth rate of 12.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 196.04M | 143.56% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |